Baader Bank Aktiengesellschaft’s Meridian Bioscience Inc VIVO Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,000	Closed	-$996K	–	492
2022 Q4	$996K	Buy	+30,000	New	+$966K	0.05%	191

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Baader Bank Aktiengesellschaft's VIVO Position: Q1 2023 in Review

Baader Bank Aktiengesellschaft sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 30,000 shares — an estimated $996K sold.

Baader Bank Aktiengesellschaft first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $996K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Baader Bank Aktiengesellschaft reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 30,000 Meridian Bioscience Inc shares in Q1 2023, an estimated $996K.
Baader Bank Aktiengesellschaft first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's Meridian Bioscience Inc position peaked at $996K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2023, filed 15 May 2023.